KTTA - Pasithea Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KTTA is currently covered by 2 analysts with an average price target of $-5.15. This is a potential upside of $-6.61 (-452.74%) from yesterday's end of day stock price of $1.46.

Pasithea Therapeutics Corp's activity chart (see below) currently has 1 price targets and 3 ratings on display. The stock rating distribution of KTTA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 338 days.

Highest price target for KTTA is $9, Lowest price target is $8, average price target is $-5.15.

Most recent stock forecast was given by ELEMER PIROS from BENCHMARK on 10-Jul-2023. First documented stock forecast 15-Dec-2021.

Best performing analysts who are covering KTTA - Pasithea Therapeutics Corp:

Constantine Davides Elemer Piros

Currently out of the existing stock ratings of KTTA, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$2

$-3.06 (-60.47%)

$2

1 years 7 months 4 days ago
(10-Jul-2023)

0/2 (0%)

$-7.22 (-78.31%)

Buy

$2

$0.09 (4.71%)

$65

1 years 10 months 10 days ago
(03-Apr-2023)

1/2 (50%)

$-6 (-75.00%)

676

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KTTA (Pasithea Therapeutics Corp) average time for price targets to be met?

On average it took 338 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?

CONSTANTINE DAVIDES

Which analyst has the current lower performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on KTTA (Pasithea Therapeutics Corp)?

Constantine Davides works at JMP and has 3 price targets and 3 ratings on KTTA

Which analyst is the currently most bullish on KTTA (Pasithea Therapeutics Corp)?

Constantine Davides with highest potential upside - $0.09

Which analyst is the currently most reserved on KTTA (Pasithea Therapeutics Corp)?

Elemer Piros with lowest potential downside - -$3.06

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?